These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27136372)
21. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal. Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors. Radwan AA; elTahir KE Arch Pharm Res; 2013 May; 36(5):553-63. PubMed ID: 23479193 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of cyclooxygenase by blocking the reducing cosubstrate at the peroxidase site: Discovery of galangin as a novel cyclooxygenase inhibitor. Bai HW; Yang C; Wang P; Rao S; Zhu BT Eur J Pharmacol; 2021 May; 899():174036. PubMed ID: 33737009 [TBL] [Abstract][Full Text] [Related]
24. Environmentally benign synthesis, molecular properties prediction and anti-inflammatory activity of novel isoxazolo[5,4-d]isoxazol-3-yl-aryl-methanones via vinylogous Henry nitroaldol adducts as synthons. Rajanarendar E; Rama Krishna S; Nagaraju D; Govardhan Reddy K; Kishore B; Reddy YN Bioorg Med Chem Lett; 2015 Apr; 25(7):1630-4. PubMed ID: 25708616 [TBL] [Abstract][Full Text] [Related]
25. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies. Bhardwaj A; Kaur J; Wuest F; Knaus EE ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205 [TBL] [Abstract][Full Text] [Related]
26. Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier. Perrone MG; Vitale P; Ferorelli S; Boccarelli A; Coluccia M; Pannunzio A; Campanella F; Di Mauro G; Bonaccorso C; Fortuna CG; Scilimati A Eur J Med Chem; 2017 Dec; 141():404-416. PubMed ID: 29032033 [TBL] [Abstract][Full Text] [Related]
27. Trimethyl-4-oxo-4,5,6,7-tetrahydroindazole-1-acetic acid: a new lead compound with selective COX-2 inhibitory activity. Abdel-Rahman HM; Ozadali K Arch Pharm (Weinheim); 2012 Nov; 345(11):878-83. PubMed ID: 22907715 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894 [TBL] [Abstract][Full Text] [Related]
29. N-1 and C-3 substituted indole Schiff bases as selective COX-2 inhibitors: synthesis and biological evaluation. Kaur J; Bhardwaj A; Huang Z; Knaus EE Bioorg Med Chem Lett; 2012 Mar; 22(6):2154-9. PubMed ID: 22361134 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study. Abdel-Aziz AA; ElTahir KE; Asiri YA Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719 [TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zarghi A; Zebardast T; Daraie B; Hedayati M Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198 [TBL] [Abstract][Full Text] [Related]
32. Synthesis, Cyclooxygenases Inhibition Activities and Interactions with BSA of Krzyżak E; Szkatuła D; Wiatrak B; Gębarowski T; Marciniak A Molecules; 2020 Jun; 25(12):. PubMed ID: 32630594 [TBL] [Abstract][Full Text] [Related]
33. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146 [TBL] [Abstract][Full Text] [Related]
34. Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio. Temml V; Kaserer T; Kutil Z; Landa P; Vanek T; Schuster D Future Med Chem; 2014; 6(17):1869-81. PubMed ID: 25495981 [TBL] [Abstract][Full Text] [Related]
35. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition. Palermo G; Favia AD; Convertino M; De Vivo M ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases. Rao PN; Chen QH; Knaus EE J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583 [TBL] [Abstract][Full Text] [Related]
38. Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. Eleftheriou P; Geronikaki A; Hadjipavlou-Litina D; Vicini P; Filz O; Filimonov D; Poroikov V; Chaudhaery SS; Roy KK; Saxena AK Eur J Med Chem; 2012 Jan; 47(1):111-24. PubMed ID: 22119153 [TBL] [Abstract][Full Text] [Related]
39. Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents. Mohammed KO; Nissan YM Chem Biol Drug Des; 2014 Oct; 84(4):473-88. PubMed ID: 24720475 [TBL] [Abstract][Full Text] [Related]